Bezircioğlu, İncim
Loading...
Profile URL
Name Variants
bezircioglu, I.
BEZIRCIOGLU, I
Bezircioglu, Incim
Bezi̇rci̇oğlu, İnci̇m
BEZIRCIOGLU, I
Bezircioglu, Incim
Bezi̇rci̇oğlu, İnci̇m
Job Title
Email Address
incim.bezircioglu@ieu.edu.tr
Main Affiliation
09.04. Surgical Sciences
Status
Current Staff
Website
ORCID ID
Scopus Author ID
Turkish CoHE Profile ID
Google Scholar ID
WoS Researcher ID
Sustainable Development Goals
1NO POVERTY
0
Research Products
2ZERO HUNGER
0
Research Products
3GOOD HEALTH AND WELL-BEING
6
Research Products
4QUALITY EDUCATION
0
Research Products
5GENDER EQUALITY
0
Research Products
6CLEAN WATER AND SANITATION
0
Research Products
7AFFORDABLE AND CLEAN ENERGY
0
Research Products
8DECENT WORK AND ECONOMIC GROWTH
0
Research Products
9INDUSTRY, INNOVATION AND INFRASTRUCTURE
0
Research Products
10REDUCED INEQUALITIES
0
Research Products
11SUSTAINABLE CITIES AND COMMUNITIES
0
Research Products
12RESPONSIBLE CONSUMPTION AND PRODUCTION
0
Research Products
13CLIMATE ACTION
0
Research Products
14LIFE BELOW WATER
0
Research Products
15LIFE ON LAND
0
Research Products
16PEACE, JUSTICE AND STRONG INSTITUTIONS
0
Research Products
17PARTNERSHIPS FOR THE GOALS
0
Research Products
Documents
30
Citations
242
h-index
9
Documents
22
Citations
190
Scholarly Output
8
Articles
5
Views / Downloads
43/69
Supervised MSc Theses
1
Supervised PhD Theses
0
WoS Citation Count
0
Scopus Citation Count
3
Patents
0
Projects
0
WoS Citations per Publication
0.00
Scopus Citations per Publication
0.38
Open Access Source
2
Supervised Theses
1
| Journal | Count |
|---|---|
| European Journal of Nuclear Medıcıne And Molecular Imagıng | 2 |
| Journal of Obstetrics and Gynaecology | 2 |
| Diagnostic Cytopathology | 1 |
| Indian Journal of Cancer | 1 |
| Journal of Clinical and Diagnostic Research | 1 |
Current Page: 1 / 1
Scopus Quartile Distribution
Competency Cloud
8 results
Scholarly Output Search Results
Now showing 1 - 8 of 8
Master Thesis Birinci Basamak Sağlık Kuruluşları Hekimlerinin Hasta Güvenliği Kültürü Hakkındaki Algılarının Belirlenmesi(İzmir Ekonomi Üniversitesi, 2023) Erdem, Mustafa; Bezi̇rci̇oğlu, İnci̇mTürkiye'deki Birinci Basamak Sağlık Kuruluşlarında çalışan aile hekimlerinin hasta güvenliği kültürü hakkındaki algılarının belirlenmesi amacıyla araştırma yapılmıştır. AHRQ anketinin Türkçe uyarlaması yapılarak birinci basamakta görev yapan 22800 aile hekimine elektronik postayla iletilmiştir. Yanıtlayan 402 katılımcı çalışmaya alınmıştır. Birinci aşamada Türkçeye uyarlanan anketin geçerlik güvenirliği, ikinci aşamada hekimlerinin hasta güvenliği kültürü hakkındaki algıları belirlenmiştir. Yapı geçerliği için KMO değeri 0,7, Bartlett's değeri ise χ2=4998,309 p<0,001 bulunmuştur. İç Tutarlılık için yapılan faktör analizine göre ölçek 10 faktöre ayrılmış ve bu faktörler ölçeğin %60,5'ni açıklamaktadır. Güvenirlik için Cronbach Alpha değeri 0,89 olarak, testi yarılanarak değerlendirildiğinde ilk 30 soru için 0,79, son 29 soru için 0,90 bulunmuştur. Aile hekimlerinin yaş ortalaması 43,3±8,2 olup, %68,3'ü erkek, %31,7'si kadındır. Anketteki kalite ve hasta güvenliği sorunlarının listesi, örgütsel öğrenme, takım çalışması boyutlarını sırasıyla %83,9, %83,3, %81,1 en yüksek olarak olumlu yanıtlamışlardır. Katılımcıların %57,6 sı iş yükü ve hızı boyutunu olumlu yanıtlamışlardır. Katılımcıların yaptıkları puanlamaya göre (1-5) ölçeğin genel puanlaması 4 olarak bulunmuştur. Kalite ve hasta güvenliği listesi boyutu ve diğer kuruluşlarla bilgi alışverişi boyutu en yüksek puanlanan (4,8 ve 4,49) boyutlardır. İş yükü ve hızı boyutu boyutlar arasında en düşük (2,69) puanlanmıştır. Boyutların ölçeğin genel puanına göre korelasyonuna bakıldığında pozitif yönde ve anlamlı düzeydedir. Sonuç olarak birinci basamak sağlık kuruluşları için hasta güvenliği kültürü anketinin geçerli ve güvenilir olduğu ve Türkiye'deki aile hekimlerinin hasta güvenliği kültürü hakkındaki algı düzeyleri yüksek olduğu söylenebilir.Article Post Hysterectomy Occurrence of Endometrial Adenocarcinoma in Association With Granulosa Cell Tumour: a Case Report(Taylor and Francis Ltd, 2016-12-06) Bezircioglu I.; Yetimalar M.H.; Ocal I.[No abstract available]Article Factors Affecting the Prognosis and Overall Survival in Patients With Uterine Papillary Serous Carcinoma(Journal of Clinical and Diagnostic Research, 2018) Bezircioglu I.; Yetimalar M.H.; Kilic D.Introduction: Uterine Papillary Serous Carcinoma (UPSC) is a prototype of Type II Endometrial Cancers (EC) and represents 5-10% of all EC. It is clinically aggressive and responsible for over 50% of relapses and deaths in EC patients. Aim: To investigate factors affecting the overall survival in patients with UPSC. Materials and Methods: Forty-three women treated for UPSC between January 2006 and October 2015 were analysed retrospectively. Subjects were included if histology revealed a minimum of 10% component of serous carcinoma. Patients who required neoadjuvant therapy were excluded. All women underwent surgical treatment with at least total hysterectomy and bilateral salpingo-oophorectomy. The effect of age, tumour size, myometrial invasion, presence of malignant peritoneal cytology, lymph node metastasis, presence of the tumour outside the uterus and in the upper abdomen on the survival were investigated. The Kaplan-Meier method was used for survival analysis. Univariate analysis was used to evaluate the importance of each parameter and log rank test was used for significance. Significant parameters were analysed by multivariate Cox regression. Results: Forty-three patients diagnosed and treated for UPSC were analysed. Out of them, 38 (88.4%) underwent surgical staging. Relapse and disease progression despite therapy was observed in 9 (20.9%) cases. The overall survival was estimated to be 46.5%. Conclusion: The present study demonstrated that myometrial invasion, lymphovascular space involvement, and presence of a tumour in the upper abdomen were statistically significant parameters affecting the overall survival in UPSC patients. © 2018, Journal of Clinical and Diagnostic Research. All rights reserved.Article Does Cervicovaginal Cytology Have a Role in the Diagnosis and Surveillance of Endometrial Adenocarcinoma?(John Wiley and Sons Inc., 2020-04-25) Kilic D.; Yetimalar M.H.; Bezircioglu I.; Yigit S.; Yigit, Seyran; Kilic, Derya; Bezircioglu, Incim; Yetimalar, Mehmet HakanObjective: To examine the role of cervicovaginal cytology in diagnoses and surveillance of the patients with endometrial carcinoma (EC). Methods: Patients who underwent EC surgery that included a follow-up were reviewed retrospectively. The cohort was limited to the patients who had an available cervical cytology result within 12 months before the primary surgery took place. The glandular abnormalities were classified in the following subclassifications: “atypical glandular cells” (AGC)-not otherwise specified (NOS), AGC-favor neoplasia, endocervical AIS, and adenocarcinoma. Results: A total of 411 patients were eligible for the study. The cervical cytology was found to be normal and recorded as negative for intraepithelial lesion or malignancy in 368 (89.5%) patients. In 43 (10.5%) patients, cervical cytology was interpreted as: AGC-NOS (n = 11), AGC-FN (n = 7), adenocarcinoma (n = 20), malignant epithelial tumor (n = 3), and squamous carcinoma (n = 2). During the follow-up, recurrence was observed in 53 (12.9%) patients. Among six isolated vaginal cuff recurrences, two of the cases presented with malignant cytology, and the additional four cases were suspected during clinical examination. Among women with recurrence (n = 53), there were malignant cytological findings in four of the patients. In the whole population (n = 411), there were four other abnormal cytological findings detected within the surveillance. These four cytology results were nonmalignant and no recurrence was identified. Conclusion: There is no significant clinical advantage of cervicovaginal cytology testing before diagnosis or during the surveillance of EC. © 2020 Wiley Periodicals, Inc.Conference Object The Role of Pet/Ct in the Detection of Residual/ Recurrent Tumor in Patients With Ovarian Cancer Whose Ca-125 Value Is Within Normal Limits(Springer, 2017) Cekin, G.; Bezircioğlu, İncim; Yigit, S.[Abstract Not Available]Article The Association of Polypoid Growth Pattern With Lymph Node Involvement in Endometrioid Type Endometrial Adenocarcinoma(Wolters Kluwer Medknow Publications, 2023) Bezircioğlu, İncim; Yetimalar, M.H.; Kılıç, D.; Yiğit, S.Background: Tumor size is an independent predictor of lymph node metastasis and survival in the endometrioid type endometrial adenocarcinoma (EC). However, some of the ECs tend to grow towards the cavity in the polypoid pattern, which can reach very large sizes. In this study, we aimed to analyze the association of growing in the polypoid pattern of the tumor with the proportion of lymph node metastasis and extrauterine tumor spread. Methods: Four hundred seven patients were analyzed retrospectively. The effect of tumor size, tumor growing pattern, myometrial invasion, grade, and lymphovascular space invasion on the lymph node metastasis and extrauterine tumor spread were investigated. Statistical analysis consisted of unpaired t-tests for parametric data and Mann Whitney-U test for non-parametric data, whereas the Chi-square test for categorical variables. Logistic Regression, Cox Regression and multivariate analysis were used to estimate the risk predictors. Results: No association was found between the growing in polypoid pattern and lymph node metastasis (P > 0.05). In the analysis of endometrioid type EC patients who had myometrial invasion less than ½ as a subgroup, no association was found between the growing pattern and lymph node metastasis and extrauterine disease. Tumor size was found to be a statistically significant predictor of lymph node metastasis and extrauterine disease (P < 0.05). Conclusions: Lymphovascular space invasion, grade, and myometrial invasion are associated with a higher proportion of lymph node metastasis. The polypoid growth pattern of the tumor does not correlate with any histopathological parameters. © 2023 Copyright:Article Citation - Scopus: 3The Impact of Uterine Adenomyosis on the Histopathological Risk Factors and Survival in Patients With Endometrial Adenocarcinoma(Taylor and Francis Ltd., 2022-03-09) Yetimalar M.H.; Kilic D.; Bezircioglu I.; Yigit S.; Yigit, Seyran; Kilic, Derya; Bezircioglu, Incim; Yetimalar, Mehmet HakanA retrospective cohort study was performed on patients diagnosed with endometrial adenocarcinoma (EC) during a 9-year period to investigate the impact of co-existing adenomyosis on patients with EC. Group A included women with EC and adenomyosis and Group B EC cases without the presence of adenomyosis. Group A was more likely to have early-stage disease, tumours without deep myometrial invasion, low-grade tumours and tumours with negative lymphovascular space invasion when compared to Group B (p = 0.012, p = 0.004, p < 0.001, p = 0.02). There were no statistically significant difference between Group A and Group B for lymph node metastasis (p = 0.064). There was no significant relation between the adenomyosis and survival outcomes in the multivariant analysis (p = 0.437). As a conclusion, patients with adenomyosis were more likely to accompany good histopathologic prognostic factors. Multivariate analysis showed no significant effect of adenomyosis on recurrence and survival parameters.IMPACT STATEMENTWhat is already known on this subject? Adenomyosis is one of the most common accompanying benign histopathological findings of type 1 endometrial carcinomas (EC). Adenomyosis comprises some characteristics similar to malignant tumours, such as invasion, abnormal tissue growth and angiogenesis. Despite concerns have arisen due to both their high incidence and similar molecular links, the possible relation between EC and adenomyosis is still not well grounded. What the results of this study add? We presented a 9-year period retrospective cohort of a tertiary referring single centre and evaluated the prognostic effect of adenomyosis in patients with EC as well as the survival outcomes of these patients. The co-occurrence of adenomyosis was more likely to accompany early-stage (stages 1–2) disease, low-grade tumours (grades 1–2) and tumours with negative LVSI in patients with EC. However, multivariate and survival analysis showed no significant effect of adenomyosis on recurrence and survival parameters. What the implications are of these findings for clinical practice and/or further research? Based on these findings, we suggest that the presence of adenomyosis should not be considered as a prognostic factor in EC. Our results support the overriding opinion about the prognostic value of co-occurrence of adenomyosis and EC. However, further studies exploring the molecular and genomic markers in these two groups are needed to uncover the exact relation of adenomyosis on the prognosis of EC. © 2022 Informa UK Limited, trading as Taylor & Francis Group.Conference Object Comparison of Diagnostic Value of Pet/Ct and Ca-125 Assay in Detection of Residual and Recurrent Tumor in Follow-Up Ovarian Cancer(Springer, 2017) Cekin, G.; Bezircioğlu, İncim; Yigit, S.[Abstract Not Available]